Pr. Wei specializes in neuroendovascular treatment of complex cerebrovascular diseases. His principal areas of expertise include endovascular treatment of intracranial aneurysms and cerebral vascular malformations; angioplasty and stenting for intracranial and extracranial atherosclerotic disease involving the carotid, vertebral, and middle cerebral arteries; and endovascular treatment of cerebral venous disorders, including cerebral venous sinus stenosis, spontaneous intracranial hypotension, and orthostatic headache.

He also has extensive expertise in the endovascular management of spinal cord and spinal vascular disorders, as well as neurointerventional treatment of vein of Galen aneurysmal malformations in infants and young children.

Clinical and Academic Achievements:

Pr. Wei was selected as a National Outstanding Young Physician in the inaugural cohort of the National High-Level Medical Talent Program and as a Tier I Talent of the Tianjin “131” Innovative Talent Development Program. He received the Outstanding Individual Award for Mechanical Thrombectomy under the National Quality Improvement Initiative for Reperfusion Therapy in Acute Ischemic Stroke, won First Prize in the inaugural Huaxia Cup Arterial Thrombectomy Skills Competition, and was named among the inaugural Top Ten Neurointerventional Surgeons in China.

With extensive experience in clinical neurointervention, Dr. Wei has performed more than 3,500 neuroendovascular procedures for complex intracranial aneurysms, cerebral vascular malformations, and cerebrovascular stenotic diseases. He has also provided specialist consultations for nearly 1,000 patients with critical and complex cerebrovascular conditions from more than 10 provinces, municipalities, and autonomous regions across China.

Pr. Wei has long been actively involved in emergency stroke care and performs more than 500 mechanical thrombectomy procedures annually for acute large-vessel occlusion. He is also dedicated to the translational development and clinical innovation of neurointerventional techniques and devices. He was the first to report the “reverse semi-retrieval” and “dual-protection” thrombectomy techniques, integrating preprocedural MRI assessment with individualized endovascular treatment strategies. These techniques have contributed to the advancement of mechanical thrombectomy strategies for acute ischemic stroke.

In research, Dr. Wei has led or participated in multiple scientific research and technology development projects, including projects supported by the National Natural Science Foundation of China, and has made a series of original contributions to the endovascular treatment of acute ischemic stroke. His research findings have been published in top-tier international medical journals, including The Lancet. He has received the first prize of the Beijing Science and Technology Progress Award and has been granted three national invention patents.